Does the media refer more to AON or MRSH?

In the previous week, Marsh & McLennan Companies had 16 more articles in the media than AON. MarketBeat recorded 45 mentions for Marsh & McLennan Companies and 29 mentions for AON. Marsh & McLennan Companies' average media sentiment score of 1.15 beat AON's score of 0.91 indicating that Marsh & McLennan Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AON 21 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Marsh & McLennan Companies 30 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to AJG or MRSH?

In the previous week, Marsh & McLennan Companies had 21 more articles in the media than Arthur J. Gallagher & Co.. MarketBeat recorded 45 mentions for Marsh & McLennan Companies and 24 mentions for Arthur J. Gallagher & Co.. Arthur J. Gallagher & Co.'s average media sentiment score of 1.35 beat Marsh & McLennan Companies' score of 1.15 indicating that Arthur J. Gallagher & Co. is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Arthur J. Gallagher & Co. 20 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Marsh & McLennan Companies 30 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MRSH or BRO?

In the previous week, Marsh & McLennan Companies had 25 more articles in the media than Brown & Brown. MarketBeat recorded 45 mentions for Marsh & McLennan Companies and 20 mentions for Brown & Brown. Marsh & McLennan Companies' average media sentiment score of 1.15 beat Brown & Brown's score of 0.99 indicating that Marsh & McLennan Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Marsh & McLennan Companies 30 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Brown & Brown 10 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CRD.B or MRSH?

Marsh & McLennan Companies has a consensus target price of $201.69, indicating a potential upside of 11.64%. Given Marsh & McLennan Companies' stronger consensus rating and higher probable upside, analysts plainly believe Marsh & McLennan Companies is more favorable than Crawford & Company. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crawford & Company 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Marsh & McLennan Companies 1 Sell rating(s) 11 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.33

Does the media refer more to CRD.B or MRSH?

In the previous week, Marsh & McLennan Companies had 44 more articles in the media than Crawford & Company. MarketBeat recorded 45 mentions for Marsh & McLennan Companies and 1 mentions for Crawford & Company. Marsh & McLennan Companies' average media sentiment score of 1.15 beat Crawford & Company's score of 0.68 indicating that Marsh & McLennan Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crawford & Company 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Marsh & McLennan Companies 30 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer EHTH or MRSH?

In the previous week, Marsh & McLennan Companies had 43 more articles in the media than eHealth. MarketBeat recorded 45 mentions for Marsh & McLennan Companies and 2 mentions for eHealth. Marsh & McLennan Companies' average media sentiment score of 1.15 beat eHealth's score of 0.94 indicating that Marsh & McLennan Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment eHealth 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Marsh & McLennan Companies 30 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Marsh & McLennan Companies (MRSH) Competitors

$180.66 +4.26 (+2.41%)

Closing price 07/24/2026 03:59 PM Eastern

Extended Trading

$181.38 +0.72 (+0.40%)

As of 07/24/2026 07:34 PM Eastern

Compare

MRSH vs. AON, AJG, BRO, CRD.B, and EHTH

Should you buy Marsh & McLennan Companies stock or one of its competitors? MarketBeat compares Marsh & McLennan Companies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Marsh & McLennan Companies include AON (AON), Arthur J. Gallagher & Co. (AJG), Brown & Brown (BRO), Crawford & Company (CRD.B), and eHealth (EHTH). These companies are all part of the "insurance brokers" industry.

How does Marsh & McLennan Companies compare to AON?

AON (NYSE:AON) and Marsh & McLennan Companies (NYSE:MRSH) are both large-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

AON has a net margin of 22.54% compared to Marsh & McLennan Companies' net margin of 14.24%. AON's return on equity of 43.50% beat Marsh & McLennan Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AON	22.54%	43.50%	7.44%
Marsh & McLennan Companies	14.24%	32.67%	8.44%

AON has a beta of 0.71, meaning that its stock price is 29% less volatile than the broader market. Comparatively, Marsh & McLennan Companies has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

In the previous week, Marsh & McLennan Companies had 16 more articles in the media than AON. MarketBeat recorded 45 mentions for Marsh & McLennan Companies and 29 mentions for AON. Marsh & McLennan Companies' average media sentiment score of 1.15 beat AON's score of 0.91 indicating that Marsh & McLennan Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AON	21 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Marsh & McLennan Companies	30 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Marsh & McLennan Companies has higher revenue and earnings than AON. AON is trading at a lower price-to-earnings ratio than Marsh & McLennan Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AON	$17.18B	4.49	$3.70B	$18.22	19.83
Marsh & McLennan Companies	$26.98B	3.20	$4.16B	$8.18	22.09

86.1% of AON shares are owned by institutional investors. Comparatively, 88.0% of Marsh & McLennan Companies shares are owned by institutional investors. 1.0% of AON shares are owned by insiders. Comparatively, 0.4% of Marsh & McLennan Companies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

AON presently has a consensus price target of $404.56, suggesting a potential upside of 11.99%. Marsh & McLennan Companies has a consensus price target of $201.69, suggesting a potential upside of 11.64%. Given AON's stronger consensus rating and higher possible upside, equities research analysts plainly believe AON is more favorable than Marsh & McLennan Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AON	0 Sell rating(s)	5 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.71
Marsh & McLennan Companies	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.33

AON pays an annual dividend of $3.28 per share and has a dividend yield of 0.9%. Marsh & McLennan Companies pays an annual dividend of $3.96 per share and has a dividend yield of 2.2%. AON pays out 18.0% of its earnings in the form of a dividend. Marsh & McLennan Companies pays out 48.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Marsh & McLennan Companies has increased its dividend for 15 consecutive years. Marsh & McLennan Companies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

AON and Marsh & McLennan Companies tied by winning 10 of the 20 factors compared between the two stocks.

How does Marsh & McLennan Companies compare to Arthur J. Gallagher & Co.?

Arthur J. Gallagher & Co. (NYSE:AJG) and Marsh & McLennan Companies (NYSE:MRSH) are both large-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations.

Arthur J. Gallagher & Co. pays an annual dividend of $2.80 per share and has a dividend yield of 1.1%. Marsh & McLennan Companies pays an annual dividend of $3.96 per share and has a dividend yield of 2.2%. Arthur J. Gallagher & Co. pays out 45.3% of its earnings in the form of a dividend. Marsh & McLennan Companies pays out 48.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Arthur J. Gallagher & Co. has raised its dividend for 15 consecutive years and Marsh & McLennan Companies has raised its dividend for 15 consecutive years.

Marsh & McLennan Companies has higher revenue and earnings than Arthur J. Gallagher & Co.. Marsh & McLennan Companies is trading at a lower price-to-earnings ratio than Arthur J. Gallagher & Co., indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arthur J. Gallagher & Co.	$13.94B	4.56	$1.49B	$6.18	40.06
Marsh & McLennan Companies	$26.98B	3.20	$4.16B	$8.18	22.09

Arthur J. Gallagher & Co. presently has a consensus price target of $280.35, suggesting a potential upside of 13.24%. Marsh & McLennan Companies has a consensus price target of $201.69, suggesting a potential upside of 11.64%. Given Arthur J. Gallagher & Co.'s stronger consensus rating and higher possible upside, equities analysts clearly believe Arthur J. Gallagher & Co. is more favorable than Marsh & McLennan Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arthur J. Gallagher & Co.	0 Sell rating(s)	5 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.72
Marsh & McLennan Companies	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.33

In the previous week, Marsh & McLennan Companies had 21 more articles in the media than Arthur J. Gallagher & Co.. MarketBeat recorded 45 mentions for Marsh & McLennan Companies and 24 mentions for Arthur J. Gallagher & Co.. Arthur J. Gallagher & Co.'s average media sentiment score of 1.35 beat Marsh & McLennan Companies' score of 1.15 indicating that Arthur J. Gallagher & Co. is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Arthur J. Gallagher & Co.	20 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Marsh & McLennan Companies	30 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Arthur J. Gallagher & Co. has a beta of 0.5, suggesting that its stock price is 50% less volatile than the broader market. Comparatively, Marsh & McLennan Companies has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market.

85.5% of Arthur J. Gallagher & Co. shares are owned by institutional investors. Comparatively, 88.0% of Marsh & McLennan Companies shares are owned by institutional investors. 1.4% of Arthur J. Gallagher & Co. shares are owned by company insiders. Comparatively, 0.4% of Marsh & McLennan Companies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Marsh & McLennan Companies has a net margin of 14.24% compared to Arthur J. Gallagher & Co.'s net margin of 10.76%. Marsh & McLennan Companies' return on equity of 32.67% beat Arthur J. Gallagher & Co.'s return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arthur J. Gallagher & Co.	10.76%	12.83%	3.89%
Marsh & McLennan Companies	14.24%	32.67%	8.44%

Summary

Marsh & McLennan Companies beats Arthur J. Gallagher & Co. on 11 of the 19 factors compared between the two stocks.

How does Marsh & McLennan Companies compare to Brown & Brown?

Marsh & McLennan Companies (NYSE:MRSH) and Brown & Brown (NYSE:BRO) are both large-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

Marsh & McLennan Companies pays an annual dividend of $3.96 per share and has a dividend yield of 2.2%. Brown & Brown pays an annual dividend of $0.66 per share and has a dividend yield of 1.0%. Marsh & McLennan Companies pays out 48.4% of its earnings in the form of a dividend. Brown & Brown pays out 21.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Marsh & McLennan Companies has raised its dividend for 15 consecutive years. Marsh & McLennan Companies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Marsh & McLennan Companies had 25 more articles in the media than Brown & Brown. MarketBeat recorded 45 mentions for Marsh & McLennan Companies and 20 mentions for Brown & Brown. Marsh & McLennan Companies' average media sentiment score of 1.15 beat Brown & Brown's score of 0.99 indicating that Marsh & McLennan Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Marsh & McLennan Companies	30 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
Brown & Brown	10 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

88.0% of Marsh & McLennan Companies shares are held by institutional investors. Comparatively, 71.0% of Brown & Brown shares are held by institutional investors. 0.4% of Marsh & McLennan Companies shares are held by company insiders. Comparatively, 13.1% of Brown & Brown shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Marsh & McLennan Companies has higher revenue and earnings than Brown & Brown. Brown & Brown is trading at a lower price-to-earnings ratio than Marsh & McLennan Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Marsh & McLennan Companies	$26.98B	3.20	$4.16B	$8.18	22.09
Brown & Brown	$5.90B	3.89	$1.05B	$3.11	21.77

Marsh & McLennan Companies currently has a consensus target price of $201.69, indicating a potential upside of 11.64%. Brown & Brown has a consensus target price of $78.63, indicating a potential upside of 16.14%. Given Brown & Brown's higher possible upside, analysts clearly believe Brown & Brown is more favorable than Marsh & McLennan Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Marsh & McLennan Companies	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.33
Brown & Brown	2 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.16

Brown & Brown has a net margin of 17.94% compared to Marsh & McLennan Companies' net margin of 14.24%. Marsh & McLennan Companies' return on equity of 32.67% beat Brown & Brown's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Marsh & McLennan Companies	14.24%	32.67%	8.44%
Brown & Brown	17.94%	12.94%	5.55%

Marsh & McLennan Companies has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market. Comparatively, Brown & Brown has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market.

Summary

Marsh & McLennan Companies beats Brown & Brown on 14 of the 19 factors compared between the two stocks.

How does Marsh & McLennan Companies compare to Crawford & Company?

Crawford & Company (NYSE:CRD.B) and Marsh & McLennan Companies (NYSE:MRSH) are both insurance brokers companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Crawford & Company has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, Marsh & McLennan Companies has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

11.0% of Crawford & Company shares are held by institutional investors. Comparatively, 88.0% of Marsh & McLennan Companies shares are held by institutional investors. 51.0% of Crawford & Company shares are held by insiders. Comparatively, 0.4% of Marsh & McLennan Companies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Marsh & McLennan Companies has higher revenue and earnings than Crawford & Company. Marsh & McLennan Companies is trading at a lower price-to-earnings ratio than Crawford & Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crawford & Company	$1.31B	0.38	$19.63M	$0.36	28.41
Marsh & McLennan Companies	$26.98B	3.20	$4.16B	$8.18	22.09

In the previous week, Marsh & McLennan Companies had 44 more articles in the media than Crawford & Company. MarketBeat recorded 45 mentions for Marsh & McLennan Companies and 1 mentions for Crawford & Company. Marsh & McLennan Companies' average media sentiment score of 1.15 beat Crawford & Company's score of 0.68 indicating that Marsh & McLennan Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Crawford & Company	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Marsh & McLennan Companies	30 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Marsh & McLennan Companies has a consensus target price of $201.69, indicating a potential upside of 11.64%. Given Marsh & McLennan Companies' stronger consensus rating and higher probable upside, analysts plainly believe Marsh & McLennan Companies is more favorable than Crawford & Company.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crawford & Company	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Marsh & McLennan Companies	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.33

Marsh & McLennan Companies has a net margin of 14.24% compared to Crawford & Company's net margin of 1.37%. Marsh & McLennan Companies' return on equity of 32.67% beat Crawford & Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crawford & Company	1.37%	24.21%	5.46%
Marsh & McLennan Companies	14.24%	32.67%	8.44%

Crawford & Company pays an annual dividend of $0.30 per share and has a dividend yield of 2.9%. Marsh & McLennan Companies pays an annual dividend of $3.96 per share and has a dividend yield of 2.2%. Crawford & Company pays out 83.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Marsh & McLennan Companies pays out 48.4% of its earnings in the form of a dividend. Marsh & McLennan Companies has increased its dividend for 15 consecutive years.

Summary

Marsh & McLennan Companies beats Crawford & Company on 16 of the 19 factors compared between the two stocks.

How does Marsh & McLennan Companies compare to eHealth?

eHealth (NASDAQ:EHTH) and Marsh & McLennan Companies (NYSE:MRSH) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

Marsh & McLennan Companies has a net margin of 14.24% compared to eHealth's net margin of 6.31%. Marsh & McLennan Companies' return on equity of 32.67% beat eHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
eHealth	6.31%	6.52%	3.17%
Marsh & McLennan Companies	14.24%	32.67%	8.44%

eHealth currently has a consensus target price of $3.25, suggesting a potential upside of 142.54%. Marsh & McLennan Companies has a consensus target price of $201.69, suggesting a potential upside of 11.64%. Given eHealth's higher probable upside, equities research analysts plainly believe eHealth is more favorable than Marsh & McLennan Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
eHealth	1 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.83
Marsh & McLennan Companies	1 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.33

eHealth has a beta of 1.48, indicating that its share price is 48% more volatile than the broader market. Comparatively, Marsh & McLennan Companies has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market.

In the previous week, Marsh & McLennan Companies had 43 more articles in the media than eHealth. MarketBeat recorded 45 mentions for Marsh & McLennan Companies and 2 mentions for eHealth. Marsh & McLennan Companies' average media sentiment score of 1.15 beat eHealth's score of 0.94 indicating that Marsh & McLennan Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
eHealth	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Marsh & McLennan Companies	30 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Marsh & McLennan Companies has higher revenue and earnings than eHealth. eHealth is trading at a lower price-to-earnings ratio than Marsh & McLennan Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
eHealth	$554.01M	0.08	$40.04M	-$0.96	N/A
Marsh & McLennan Companies	$26.98B	3.20	$4.16B	$8.18	22.09

79.5% of eHealth shares are held by institutional investors. Comparatively, 88.0% of Marsh & McLennan Companies shares are held by institutional investors. 7.2% of eHealth shares are held by company insiders. Comparatively, 0.4% of Marsh & McLennan Companies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Marsh & McLennan Companies beats eHealth on 14 of the 17 factors compared between the two stocks.

Get Marsh & McLennan Companies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRSH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MRSH vs. The Competition

Export

Metric	Marsh & McLennan Companies	INS Industry	Finance Sector	NYSE Exchange
Market Cap	$86.25B	$22.52B	$14.47B	$23.58B
Dividend Yield	2.19%	1.71%	5.71%	4.21%
P/E Ratio	22.09	21.04	20.66	30.98
Price / Sales	3.20	99.74	44.69	19.98
Price / Cash	15.47	12.12	19.27	32.09
Price / Book	5.59	3.10	2.25	4.73
Net Income	$4.16B	$1.06B	$1.14B	$1.07B
7 Day Performance	-0.85%	-1.75%	-0.48%	-0.45%
1 Month Performance	7.01%	7.20%	0.41%	-0.41%
1 Year Performance	N/A	-21.78%	12.27%	14.19%

Marsh & McLennan Companies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MRSH Marsh & McLennan Companies	N/A	$180.66 +2.4%	$201.69 +11.6%	N/A	$86.25B	$26.98B	22.09	95,000	News Coverage Positive News Earnings Report Analyst Downgrade
AON AON	4.0839 of 5 stars	$362.73 -1.2%	$404.56 +11.5%	-3.1%	$78.43B	$17.18B	20.55	60,000	News Coverage Upcoming Earnings
AJG Arthur J. Gallagher & Co.	4.6291 of 5 stars	$253.77 -0.1%	$280.35 +10.5%	-21.4%	$65.23B	$13.94B	22.08	72,000	News Coverage Positive News Upcoming Earnings
BRO Brown & Brown	4.2359 of 5 stars	$68.97 -0.5%	$78.63 +14.0%	-34.5%	$23.51B	$5.90B	15.76	7,905	News Coverage Upcoming Earnings Dividend Announcement
CRD.B Crawford & Company	1.4756 of 5 stars	$10.11 -1.2%	N/A	-1.8%	$498.62M	$1.31B	12.03	9,943	News Coverage Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MRSH) was last updated on 7/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Marsh & McLennan Companies (MRSH) Competitors

MRSH vs. AON, AJG, BRO, CRD.B, and EHTH

How does Marsh & McLennan Companies compare to AON?

Summary

How does Marsh & McLennan Companies compare to Arthur J. Gallagher & Co.?

Summary

How does Marsh & McLennan Companies compare to Brown & Brown?

Summary

How does Marsh & McLennan Companies compare to Crawford & Company?

Summary

How does Marsh & McLennan Companies compare to eHealth?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MRSH vs. The Competition

Marsh & McLennan Companies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Marsh & McLennan Companies (MRSH) Competitors

MRSH vs. AON, AJG, BRO, CRD.B, and EHTH

How does Marsh & McLennan Companies compare to AON?

Is AON or MRSH more profitable?

Which has more volatility & risk, AON or MRSH?

Does the media refer more to AON or MRSH?

Which has better earnings and valuation, AON or MRSH?

Do insiders & institutionals believe in AON or MRSH?

Do analysts prefer AON or MRSH?

Is AON or MRSH a better dividend stock?

Summary

How does Marsh & McLennan Companies compare to Arthur J. Gallagher & Co.?

Is AJG or MRSH a better dividend stock?

Which has better earnings & valuation, AJG or MRSH?

Do analysts prefer AJG or MRSH?

Does the media refer more to AJG or MRSH?

Which has more risk & volatility, AJG or MRSH?

Do institutionals and insiders believe in AJG or MRSH?

Is AJG or MRSH more profitable?

Summary

How does Marsh & McLennan Companies compare to Brown & Brown?

Is MRSH or BRO a better dividend stock?

Does the media refer more to MRSH or BRO?

Do institutionals and insiders hold more shares of MRSH or BRO?

Which has better valuation & earnings, MRSH or BRO?

Do analysts recommend MRSH or BRO?

Is MRSH or BRO more profitable?

Which has more risk & volatility, MRSH or BRO?

Summary

How does Marsh & McLennan Companies compare to Crawford & Company?

Which has more risk & volatility, CRD.B or MRSH?

Do insiders & institutionals have more ownership in CRD.B or MRSH?

Which has preferable valuation and earnings, CRD.B or MRSH?

Does the media refer more to CRD.B or MRSH?

Do analysts rate CRD.B or MRSH?

Is CRD.B or MRSH more profitable?

Is CRD.B or MRSH a better dividend stock?

Summary

How does Marsh & McLennan Companies compare to eHealth?

Is EHTH or MRSH more profitable?

Do analysts prefer EHTH or MRSH?

Which has more risk and volatility, EHTH or MRSH?

Does the media prefer EHTH or MRSH?

Which has better valuation & earnings, EHTH or MRSH?

Do institutionals and insiders hold more shares of EHTH or MRSH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MRSH vs. The Competition

Marsh & McLennan Companies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools